References
- Crichton RR. 1973. The biochemistry of ferritin. British Journal of Haematology 24:677–680.
- Eghbali A, Taherahmadi H, Shahbazi M, Bagheri B, Ebrahimi L. 2014. Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major beta-thalassemia. Iranian Journal of Pediatric Hematology and Oncology 4:17–21.
- Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. 2008. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance: Official Journal of the Society for Cardiovascular Magnetic Resonance 10:42.
- Nassar AH, Usta IM, Rechdan JB, Koussa S, Inati A, Taher AT. 2006a. Pregnancy in patients with beta-thalassemia intermedia: outcome of mothers and newborns. American Journal of Hematology 81:499–502.
- Nassar AH, Usta IM, Taher AM. 2006b. Beta-thalassemia intermedia and pregnancy: should we anticoagulate? Journal of Thrombosis and Haemostasis 4:1413–1414.
- Porter JB, Garbowski M. 2014. The pathophysiology of transfusional iron overload. Hematology Oncology Clinics of North America 28:683–701, vi.
- Puolakka J, Janne O, Pakarinen A, Jarvinen PA, Vihko R. 1980. Serum ferritin as a measure of iron stores during and after normal pregnancy with and without iron supplements. Acta Obstetricia Et Gynecologica Scandinavica 95:43–51.
- Singer ST, Vichinsky EP. 1999. Deferoxamine treatment during pregnancy: is it harmful? American Journal of Hematology 60:24–26.
- Tamura T, Goldenberg RL, Johnston KE, Cliver SP, Hickey CA. 1996. Serum ferritin: a predictor of early spontaneous preterm delivery. Obstetrics and Gynecology 87:360–365.
- Toumba M, Sergis A, Kanaris C, Skordis N. 2007. Endocrine complications in patients with Thalassaemia major. Pediatric Endocrinology Reviews 5:642–648.
- Worwood M. 1977. The clinical biochemistry of iron. Seminars in Hematology 14:3–30.